MPWT
NGM

MassMutual Private Wealth & Trust’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-334
Closed -$2K – 1918
2022
Q4 		$2K Buy
334
+197
+144% +$1.24K ﹤0.01% 1365
2022
Q3 		$2K Buy
+137
New +$2.08K ﹤0.01% 1321
2022
Q1 		– Sell
-34
Closed -$1K – 1668
2021
Q4 		$1K Buy
+34
New +$652 ﹤0.01% 1350

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

MassMutual Private Wealth & Trust's NGM Position: Q1 2023 in Review

MassMutual Private Wealth & Trust sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q1 2023, closing a stake of 334 shares — an estimated $2K sold.

MassMutual Private Wealth & Trust first reported a position in NGM in Q4 2021 and held it in 3 quarters. The position peaked at $2K in Q4 2022. 122 funds tracked by Wall St. Rank hold NGM as of Q1 2023.

  • MassMutual Private Wealth & Trust reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 334 NGM Biopharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $2K.
  • MassMutual Private Wealth & Trust first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • MassMutual Private Wealth & Trust's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $2K in Q4 2022.
  • 122 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2023, filed 11 Apr 2023.